Scrivo R, Spadaro A, Riccieri V, Bombardieri M, Di Franco M, Celestino D, Valesini G
Cattedra di Reumatologia, Dipartimento di Clinica e Terapia Medica Applicata, Azienda Policlinico Umberto I, Università di Roma La Sapienza, Viale del Policlinico, 155 - 00161 Roma, Italia.
Reumatismo. 2005 Dec;57(4):250-5. doi: 10.4081/reumatismo.2005.250.
P-selectin is an adhesion molecule expressed by activated endothelial cells and platelets favouring the leukocyte adherence to microvascular endothelium. A soluble form of this molecule has been described, whose serum levels were found to be elevated and correlate with disease activity in rheumatoid arthritis (RA) patients. Aim of this study was to determine soluble P-selectin levels in synovial fluid (SF) and serum from patients with psoriatic arthritis (PsA), where it has never been investigated, to define its involvement in PsA synovial damage.
we analysed, by ELISA, soluble P-selectin serum and SF levels in 100 patients presenting a knee joint effusion: 38 of them presented PsA, 40 RA and 22 osteoarthritis (OA). We examined the main clinical and laboratory parameters of these patients. Soluble P-selectin serum levels were also detected in 15 healthy subjects.
soluble P-selectin SF levels were significantly higher in PsA and RA patients respect to OA subjects. Soluble P-selectin SF levels were lower than those found in serum and the SF/serum ratio was higher in PsA and RA patients respect to OA. Soluble P-selectin serum levels were not significantly different among patients and controls. No correlation was found between SF and serum levels of soluble P-selectin and the main clinical parameters.
our study of soluble P-selectin in PsA reveals a prominent local role of this molecule, with no differences respect to RA. Histological findings may be of help in understanding the role of this adhesion molecule in PsA.
P-选择素是一种由活化的内皮细胞和血小板表达的黏附分子,有利于白细胞黏附于微血管内皮。已经描述了该分子的一种可溶性形式,其血清水平在类风湿性关节炎(RA)患者中升高且与疾病活动相关。本研究的目的是测定银屑病关节炎(PsA)患者滑液(SF)和血清中的可溶性P-选择素水平,此前从未对其进行过研究,以确定其在PsA滑膜损伤中的作用。
我们通过酶联免疫吸附测定(ELISA)分析了100例膝关节积液患者的血清和SF中可溶性P-选择素水平:其中38例为PsA患者,40例为RA患者,22例为骨关节炎(OA)患者。我们检查了这些患者的主要临床和实验室参数。还检测了15名健康受试者的血清可溶性P-选择素水平。
与OA患者相比,PsA和RA患者的SF中可溶性P-选择素水平显著更高。PsA和RA患者的SF中可溶性P-选择素水平低于血清中的水平,且SF/血清比值高于OA患者。患者和对照组之间的血清可溶性P-选择素水平无显著差异。可溶性P-选择素的SF和血清水平与主要临床参数之间未发现相关性。
我们对PsA中可溶性P-选择素的研究揭示了该分子的突出局部作用,与RA无差异。组织学研究结果可能有助于理解这种黏附分子在PsA中的作用。